Localization of Potential Energy in Hydrogen Bonds of the ATXN2 Gene
Mikhail Drobotenko,
No information about this author
Oksana Lyasota,
No information about this author
С. С. Джимак
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 933 - 933
Published: Jan. 23, 2025
It
is
known
that
a
number
of
neurodegenerative
diseases,
also
called
diseases
waiting,
are
associated
with
the
expansion
polyQ
tract
in
first
exon
ATXN2
gene.
In
expanded
tract,
probability
occurrence
non-canonical
configurations
(hairpins,
G-quadruplexes,
etc.)
significantly
higher
than
normal
one.
Obviously,
for
their
formation,
open
states
(OSs)
necessary.
Calculations
were
made
these
processes
using
angular
mechanical
model
DNA.
has
been
established
large
OS
zones
genesis
DNA
segment
depends
not
only
on
“strength”
nucleotide
sequence
but
factors
determining
dynamics
DNA;
localization
energy
molecule
and
potential
interaction
between
pairs
nitrogenous
bases
depend
environmental
parameters.
The
hydrogen
bonds
does
remain
constant,
oscillatory
movements
lead
to
its
redistribution
localization.
this
case,
OSs
effectively
dissipate
oscillations.
Thus,
mathematical
modeling
makes
it
possible
calculate
energy,
which
necessary
predict
places
origin,
taking
into
account
oscillations
molecule.
Language: Английский
Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality
Xiangle Zhang,
No information about this author
Hongwei Yue,
No information about this author
Yajun Liu
No information about this author
et al.
iScience,
Journal Year:
2025,
Volume and Issue:
28(3), P. 112025 - 112025
Published: Feb. 13, 2025
Language: Английский
The LSmAD Domain of Ataxin-2 Modulates the Structure and RNA Binding of Its Preceding LSm Domain
Cells,
Journal Year:
2025,
Volume and Issue:
14(5), P. 383 - 383
Published: March 6, 2025
Ataxin-2
(Atx2),
an
RNA-binding
protein,
plays
a
pivotal
role
in
the
regulation
of
RNA,
intracellular
metabolism,
and
translation
within
cellular
environment.
Although
both
Sm-like
(LSm)
LSm-associated
(LSmAD)
domains
are
considered
to
associated
with
RNA
binding,
there
is
still
lack
experimental
evidence
supporting
their
functions.
To
address
this,
we
designed
constructed
several
recombinants
containing
domain
(RBD)
Atx2.
By
employing
biophysical
biochemical
techniques,
such
as
EMSA
SHAPE
chemical
detection,
identified
that
LSm
responsible
for
whereas
LSmAD
alone
does
not
bind
RNA.
NMR
small-angle
X-ray
scattering
(SAXS)
analyses
have
revealed
exhibits
limited
structural
integrity
poor
folding
capability.
The
data
confirmed
LSm-LSmAD
cannot,
suggesting
may
serve
auxiliary
domain.
probing
further
demonstrates
binds
AU-rich,
GU-rich,
or
CU-rich
sequence,
but
CA-rich
sequence.
These
findings
indicate
Atx2
can
interact
U-rich
sequences
3'-UTR,
implicating
its
poly(A)
tailing
mRNA
degradation.
Language: Английский
ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 11, 2025
Abstract
The
cytoplasmic
Ataxin-2
(ATXN2)
protein
associates
with
TDP-43
in
stress
granules
(SG)
where
RNA
quality
control
occurs.
Mutations
this
pathway
underlie
Spinocerebellar
Ataxia
type
2
(SCA2)
and
Amyotrophic
Lateral
Sclerosis.
In
contrast,
Ataxin-2-like
(ATXN2L)
is
predominantly
nuclear,
more
abundant,
essential
for
embryonic
life.
Its
sequestration
into
ATXN2
aggregates
may
contribute
to
disease.
study,
we
utilized
two
approaches
clarify
the
roles
of
ATXN2L.
First,
identified
interactors
through
co-immunoprecipitation
both
wild-type
ATXN2L-null
murine
fibroblasts.
Second,
assessed
proteome
profile
effects
using
mass
spectrometry
these
cells.
Additionally,
examined
accumulation
ATXN2L
SCA2
mouse
model,
Atxn2-CAG100-KnockIn
(KIN).
We
observed
that
RNA-binding
proteins,
including
PABPN1,
NUFIP2,
MCRIP2,
RBMS1,
LARP1,
PTBP1,
FMR1,
RPS20,
FUBP3,
MBNL2,
ZMAT3,
SFPQ,
CSDE1,
HNRNPK,
HNRNPDL,
exhibit
a
stronger
association
compared
established
like
ATXN2,
PABPC1,
LSM12,
G3BP2.
interacted
components
actin
complex,
such
as
SYNE2,
LMOD1,
ACTA2,
FYB,
GOLGA3.
noted
oxidative
increased
HNRNPK
but
decreased
SYNE2
association,
which
likely
reflects
relocalization
SG.
Proteome
profiling
revealed
NUFIP2
are
depleted
Furthermore,
homodimers
SYNE1
accumulate
during
aggregation
process
KIN
14-month-old
spinal
cord
tissues.
functions
its
therefore
critical
granule
trafficking
surveillance,
particularly
maintenance
differentiated
neurons.
Language: Английский
ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation
Neurobiology of Disease,
Journal Year:
2025,
Volume and Issue:
209, P. 106903 - 106903
Published: April 11, 2025
Language: Английский
Targets and Gene Therapy of ALS (Part 1)
O. A. Shiryaeva,
No information about this author
Christina A. Tolochko,
No information about this author
Т. М. Алексеева
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 4063 - 4063
Published: April 25, 2025
Amyotrophic
lateral
sclerosis
(ALS)
is
a
neurodegenerative
disease
characterized
by
the
selective
death
of
motor
neurons,
which
causes
muscle
atrophy.
Genetic
forms
ALS
are
recorded
only
in
10%
cases.
However,
over
past
decade,
studies
genetics
have
substantially
contributed
to
our
understanding
molecular
mechanisms
underlying
ALS.
The
identification
key
mutations
such
as
SOD1,
C9orf72,
FUS,
and
TARDBP
has
led
development
targeted
therapy
that
gradually
being
introduced
into
clinical
trials,
opening
up
broad
range
opportunities
for
correcting
these
mutations.
In
this
review,
we
aimed
present
an
extensive
overview
currently
known
neuron
degeneration
associated
with
genes
also
gene
methods
inhibiting
expression
their
mutant
proteins.
Among
these,
antisense
oligonucleotides,
RNA
interference
(siRNA
miRNA),
gene-editing
(CRISPR/Cas9)
particular
interest.
Each
shown
its
efficacy
animal
models
when
targeting
genes,
whereas
some
them
proven
be
efficient
human
trials.
Language: Английский
Characterization of the association and sequestration of RNA-binding proteins by single-stranded DNA chimera
Jianyang Wang,
No information about this author
Wen-Liang Guan,
No information about this author
Lei‐Lei Jiang
No information about this author
et al.
Acta Biochimica et Biophysica Sinica,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 1, 2024
Language: Английский
The Potential of Mesenchymal Stem Cells in Treating Spinocerebellar Ataxia: Advances and Future Directions
Gi Beom Lee,
No information about this author
Saeyoung Park,
No information about this author
Un Ju Jung
No information about this author
et al.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2507 - 2507
Published: Nov. 1, 2024
Spinocerebellar
ataxia
(SCA)
is
a
heterogeneous
disorder
characterized
by
impaired
balance
and
coordination
caused
cerebellar
dysfunction.
The
absence
of
treatments
approved
the
U.S.
Food
Drug
Administration
for
SCA
has
driven
investigation
alternative
therapeutic
strategies,
including
stem
cell
therapy.
Mesenchymal
cells
(MSCs),
known
their
multipotent
capabilities,
have
demonstrated
significant
potential
in
treating
SCA.
This
review
examines
how
MSCs
may
promote
neuronal
growth,
enhance
synaptic
connectivity,
modulate
brain
inflammation.
Recent
findings
from
preclinical
clinical
studies
are
also
reviewed,
emphasizing
promise
MSC
therapy
addressing
unmet
needs
patients.
Furthermore,
ongoing
trials
future
directions
proposed
to
address
limitations
current
approaches.
Language: Английский
Spinal cord phosphoproteome of a SCA2/ALS13 mouse model reveals alteration of ATXN2-N-term SH3-actin interactome and of autophagy via WNK1-MYO6-OPTN-SQSTM1
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 6, 2024
Abstract
Toxic
polyglutamine
(polyQ)
expansions
in
ATXN2
trigger
neurodegenerative
processes,
causing
Spinocerebellar
Ataxia
type
2
(SCA2),
and
enhancing
TDP-43-dependent
pathology
Amyotrophic
Lateral
Sclerosis
(ALS)
/
Fronto-Temporal
Dementia
(FTD).
Primary
disease
events
can
be
compensated
transiently,
delaying
manifestation.
To
define
potential
therapy
targets,
we
documented
how
cells
modify
their
phospho-signals
the
interactome
changes,
using
preferentially
affected
nervous
tissues
from
end-stage
Atxn2
-CAG100-KnockIn
mice.
The
spinal
cord
phosphorylome
revealed
massive
hyperphosphorylations
flanking
polyQ
expansion
for
SQSTM1,
moderate
also
ALS
proteins
OPTN,
UBQLN2,
TNIP1
TBK1-targeted
TAX1BP1,
versus
strong
hypophosphorylations
of
WNK1,
SPARCL1
PSMD9.
Significant
enrichments
SH3-containing
proteins,
autophagy
endocytosis
factors,
actin
modulators
could
explained
by
N-terminal,
polyQ-adjacent,
proline-rich
motifs
ATXN2.
Coimmunoprecipitation
profiling
cerebellum
known
associations
with
RNA-binding
like
PABPC1
TDP-43
its
modifier
PPIA
to
decrease
upon
expansion,
contrasting
increased
binding
SH3-proteins,
MYO6,
RPL21
DLG4.
Validation
protein
mRNA
levels
mouse
cord,
embryonic
fibroblasts
or
patient
after
bafilomycin
arsenite
treatment,
observed
polyQ-dependent
OPTN
deficiency
SQSTM1
induction
impairment.
Overall,
this
combined
phosphoproteome
study
efficiently
key
pathways
molecular
events.
Language: Английский